Dapagliflozin 5/10mg

This tablet contains Dapagliflozin and belongs to the group of SGLT2 inhibitor antidiabetic products. It is used in the management of type 2 diabetes mellitus, heart failure and chronic kidney disease, in line with standard clinical indications for this class.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.